Ads
related to: lexus ux 300e review- L/Certified Inventory
Shop a Collection of Hand-Selected
Certified Pre-Owned Lexus Vehicles.
- Research New Models
Browse Our Impressive Selection of
New Lexus Models Today.
- Hours & Directions
Visit a Luxury Dealer Today.
Find Dealership Hours & Directions.
- Lexus Electrified
Explore the Thrilling Performance
of Lexus Electrified.
- L/Certified Benefits
Enjoy an Unlimited-Mileage Warranty
Up to Six Years and Other Offers.
- Explore Financing Options
Speak to a Consultant to Find
Personalized Financial Solutions.
- L/Certified Inventory
Search results
Results From The WOW.Com Content Network
The Lexus UX (Japanese: レクサス・UX, Hepburn: Rekusasu UX) is a subcompact luxury crossover SUV from Lexus, a luxury division of Toyota.It was introduced at the March 2018 Geneva Motor Show as the smallest crossover model in Lexus' lineup prior to the introduction of LBX in 2023, it is currently slotted above the subcompact LBX and below the compact NX.
2021 Lexus NX 250/NX 350/NX 350h/NX 450h+ UX: subcompact luxury crossover FWD/AWD. 2018 Lexus UX 200/UX 250h; 2020 Lexus UX 300e; 2024 Lexus UX 300h; RX: full-size crossover FWD/AWD. 1999 Lexus RX 300; 2004 Lexus RX 330; 2006 Lexus RX 400h; 2007 Lexus RX 350; 2010 Lexus RX 350/RX 450h; 2011 Lexus RX 270; 2013 Lexus RX 270/RX 350/RX 450h; 2015 ...
In October 2019, Lexus announced that it will be launching the brand's first all-battery electric vehicle in 2020, which is the UX 300e. [140] [141] In June 2023, Lexus introduced its first vehicle in the B-segment, the LBX, which went on sale in Europe, Japan, Australia and Southeast Asia. [142] [143] [144]
[2] [3] The RZ is built on the e-TNGA platform shared with the Toyota bZ4X/Subaru Solterra, [4] it is the first dedicated battery electric vehicle of the Lexus marque that will be sold worldwide and also the second battery electric model after the ICE-based UX 300e. [5]
Unconventional Spanish-language movie musical "Emilia Pérez" may be an Oscars front-runner, but some feel the film is "torturous" and "harmful."
By Steven Brill Letter From the Editors Backstage at Johnson & Johnson. On May 20, about 100 stock analysts gathered in the ballroom of the Hyatt Regency Hotel in New Brunswick, New Jersey, to hear good news from top executives at Johnson & Johnson: The company had 10 new drugs in the pipeline that might achieve more than a billion dollars in annual sales.